Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
Ricchi P, Meloni A, Pistoia L, Spasiano A, Rita Gamberini M, Maggio A, Gerardi C, Messina G, Campisi S, Allò M, Renne S, Righi R, Midiri M, Positano V, Filosa A, Pepe A. Ricchi P, et al. Among authors: gerardi c. Br J Haematol. 2020 Oct;191(1):107-114. doi: 10.1111/bjh.16753. Epub 2020 May 19. Br J Haematol. 2020. PMID: 32427352 Free article.
Alpha interferon treatment of chronic hepatitis C in beta-thalassaemia.
Di Marco V, Lo Iacono O, Capra M, Grutta S, Ciaccio C, Gerardi C, Maggio A, Renda D, Almasio P, Pisa R, et al. Di Marco V, et al. Among authors: gerardi c. Gut. 1993;34(2 Suppl):S142-3. doi: 10.1136/gut.34.2_suppl.s142. Gut. 1993. PMID: 8314484 Free PMC article.
Potential myocardial iron content evaluation by magnetic resonance imaging in thalassemia major patients treated with Deferoxamine or Deferiprone during a randomized multicenter prospective clinical study.
Galia M, Midiri M, Bartolotta V, Morabito A, Rizzo M, Mangiagli A, Malizia R, Borsellino Z, Capra M, D'Ascola DG, Magnano C, Gerardi C, Rigano P, Maggio A; Multicenter Trial Group of the Society for the Study of Thalassemia and Haemoglobinopathies. Galia M, et al. Among authors: gerardi c. Hemoglobin. 2003 May;27(2):63-76. doi: 10.1081/hem-120021538. Hemoglobin. 2003. PMID: 12779268 Clinical Trial.
Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Magnano C, Rizzo M, Caruso V, Gerardi C, Argento C, Campisi S, Cantella F, Commendatore F, D'Ascola DG, Fidone C, Ciancio A, Galati MC, Giuffrida G, Cingari R, Giugno G, Lombardo T, Prossomariti L, Malizia R, Meo A, Roccamo G, Romeo MA, Violi P, Cianciulli P, Rigano P. Maggio A, et al. Among authors: gerardi c. Blood Cells Mol Dis. 2009 May-Jun;42(3):247-51. doi: 10.1016/j.bcmd.2009.01.002. Epub 2009 Feb 23. Blood Cells Mol Dis. 2009. PMID: 19233692 Clinical Trial.
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.
Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C. Maggio A, et al. Among authors: gerardi c. Br J Haematol. 2009 Apr;145(2):245-54. doi: 10.1111/j.1365-2141.2009.07609.x. Epub 2009 Feb 19. Br J Haematol. 2009. PMID: 19236376 Free article. Clinical Trial.
Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.
Pantalone GR, Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C. Pantalone GR, et al. Among authors: gerardi c. Hemoglobin. 2011;35(3):206-16. doi: 10.3109/03630269.2011.570674. Hemoglobin. 2011. PMID: 21599433 Clinical Trial.
Feasibility, reproducibility, and reliability for the T*2 iron evaluation at 3 T in comparison with 1.5 T.
Meloni A, Positano V, Keilberg P, De Marchi D, Pepe P, Zuccarelli A, Campisi S, Romeo MA, Casini T, Bitti PP, Gerardi C, Lai ME, Piraino B, Giuffrida G, Secchi G, Midiri M, Lombardi M, Pepe A. Meloni A, et al. Among authors: gerardi c. Magn Reson Med. 2012 Aug;68(2):543-51. doi: 10.1002/mrm.23236. Epub 2011 Nov 29. Magn Reson Med. 2012. PMID: 22127999 Free article.
Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients.
Maggio A, Vitrano A, Lucania G, Capra M, Cuccia L, Gagliardotto F, Pitrolo L, Prossomariti L, Filosa A, Caruso V, Gerardi C, Campisi S, Cianciulli P, Rizzo M, D'Ascola G, Ciancio A, Di Maggio R, Calvaruso G, Pantalone GR, Rigano P. Maggio A, et al. Among authors: gerardi c. Am J Hematol. 2012 Jul;87(7):732-3. doi: 10.1002/ajh.23219. Epub 2012 May 24. Am J Hematol. 2012. PMID: 22622672 Free article. Clinical Trial.
145 results